Program Services

MBR has extensive experience in managing preclinical studies and issues within multi-disciplinary project teams for both early- and late-stage drug programs. Our acquired knowledge in the pharmaceutical industry ensures clients that both their GLP-compliant and early-learning screening studies, as well as IND/CTD documents, will be expertly designed, executed, and reported to achieve successful milestones. As previous core members on internal project teams, we know how to deliver cost-effective and robust study data/reports with cycle times that optimize project timelines.